-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rebyota in Crohn’s Disease (Regional Enteritis)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Rebyota in Crohn's Disease (Regional Enteritis) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Rebyota in Crohn's Disease (Regional Enteritis) Drug Details: Fecal microbiota,...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – GSK-2904545A in Clostridioides difficile Infections (Clostridium difficile Associated Disease)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - GSK-2904545A in Clostridioides difficile Infections (Clostridium difficile Associated Disease) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data.GSK-2904545A in Clostridioides difficile Infections (Clostridium difficile Associated...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Polycab in Clostridioides difficile Infections (Clostridium difficile Associated Disease)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.PolyCAb in Clostridioides difficile Infections (Clostridium difficile Associated Disease) Drug Details:PolyCAb is under development for the...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Ribaxamase in Graft Versus Host Disease (GVHD)
Empower your strategies with our Likelihood of Approval and Phase Transition Success Rate Model - Ribaxamase in Graft Versus Host Disease (GVHD) report and make more profitable business decisions.This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalData’s proprietary machine learning algorithms developed using over 10 years of historical data. Ribaxamase in Graft Versus Host Disease (GVHD) Drug Details:...
-
Product Insights
NewLikelihood of Approval and Phase Transition Success Rate Model – Rebyota in Crohn’s Disease (Regional Enteritis)
OverviewHow likely is it that a drug will get approved? Will the drug transition to the next phase of its clinical pathway? This report provides you with the data that allows you to track and predict the specific likelihood of approval (LOA) and phase transition success rate (PTSR) of a drug using GlobalDatas proprietary machine learning algorithms developed using over 10 years of historical data.Rebyota in Crohn's Disease (Regional Enteritis) Drug Details:Fecal microbiota, live-jslm (Rebyota) is an opaque first fecal...
-
Product Insights
Auto-Immune Diseases Pipeline by Development Stages, Segments, Region and Countries, Regulatory Path and Key Companies
Auto-immune diseases Pipeline Market Report Overview Auto-immune diseases are used for detection of autoimmune disorder by identifying auto-antibodies in the patient’s test sample. The auto-immune diseases pipeline market research report provides a comprehensive understanding of the pipeline products and their comparative analysis at various stages of development. The report also includes information about the territories wherein the clinical trials are in progress, the regulatory paths followed by the trials, and the companies associated with the trials. Key Territories ·       The...
-
Product Insights
Inflammatory Disease Markers Pipeline by Stages of Development, Segments, Region, Regulatory Path and Key Companies
Inflammatory Disease Markers Pipeline Market Report Overview Inflammatory Disease Markers are antigens/antibodies that detect specific antigens/antibodies produced by bone, cartilage, or any other inflammatory disease activity. The Inflammatory Disease Markers pipeline market research report provides comprehensive information about the inflammatory disease markers pipeline products with a comparative analysis of the products at various stages of development and information about the clinical trials that are in progress. Key Segments ·       Anti-Cyclic Citrullinated Peptide Antibody (Anti-CCP) Analyzer Tests ·       C-Reactive Protein (CRP)...
-
Company Profile
CDI Corp – Company Profile
CDI Corp (CDI) is a provider of architecture and engineering, procurement, and construction management services. The company’s major services include architecture, aviation infrastructure, building systems engineering, civil engineering, construction support, electrical and power systems engineering, environmental sciences, geosciences, and geotechnical services, instrumentation and control systems, marine engineering, mechanical engineering and piping design, process engineering, procurement and supply chain management, project management and structural engineering. It serves chemicals, energy, and infrastructure markets. CDI is headquartered in Philadelphia, Pennsylvania, the US.
Add to Basket -
Company Profile
NewAssembly Biosciences Inc – Company Profile
Assembly Biosciences Inc (Assembly) is a biotechnology company that develops, discovers, and commercializes small molecule therapies. The company develops therapies for the treatment of viral diseases. Its pipeline products include ABI-5366- HSV-2 Long Acting Helicase Inhibitor, Pan-Herpes Polymerase Inhibitor(NNPI) are for the treatment of Herpes viruses. HBV/HDV Entry Inhibitor, Interferon- a Receptor Against, ABI-H3733, ABI-4334 among others. The company owns and operates its research and development facilities located in New York, Indiana and California, the US. Assembly is headquartered in...
Add to Basket -
Company Profile
Churchill Downs Incorporated – Company Profile
Churchill Downs Incorporated (CDI) is a provider of casino gaming, pari-mutuel horseracing, entertainment, and a source of online account wagering on horseracing events. It provides gaming products through its casino in Mississippi, slot and video poker operations in Louisiana and slot operations in Florida. CDI properties include Big Fish Games, Calder Casino, Arlington International, Churchill Downs Racetrack, Fair Grounds Race Course & Slots, Harlow's Casino Resort & Spa, Miami Valley Gaming & Racing, Oxford Casino, Lady Luck Casino Nemacolin, Presque...
Add to Basket